207 related articles for article (PubMed ID: 24305042)
1. Human T-lymphotropic virus/HIV co-infection: a clinical review.
Dhasmana D; Taylor GP
Curr Opin Infect Dis; 2014 Feb; 27(1):16-28. PubMed ID: 24305042
[TBL] [Abstract][Full Text] [Related]
2. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
[TBL] [Abstract][Full Text] [Related]
3. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
Brites C; Sampalo J; Oliveira A
AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
5. Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
Gudo ES; Bhatt NB; Augusto O; Semá C; Savino W; Ferreira OC; Jani IV
Int J STD AIDS; 2012 Oct; 23(10):717-23. PubMed ID: 23104746
[TBL] [Abstract][Full Text] [Related]
6. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.
Oo Z; Barrios CS; Castillo L; Beilke MA
J Med Virol; 2015 May; 87(5):790-7. PubMed ID: 25678365
[TBL] [Abstract][Full Text] [Related]
7. Neurological aspects of HIV/human T lymphotropic virus coinfection.
Tulius Silva M; de Melo Espíndola O; Bezerra Leite AC; Araújo A
AIDS Rev; 2009; 11(2):71-8. PubMed ID: 19529747
[TBL] [Abstract][Full Text] [Related]
8. Laboratory study of HIV-1 and HTLV-I/II coinfection.
Beilke MA; Greenspan DL; Impey A; Thompson J; Didier PJ
J Med Virol; 1994 Oct; 44(2):132-43. PubMed ID: 7852953
[TBL] [Abstract][Full Text] [Related]
9. Human T-cell lymphotropic virus in patients infected with HIV-1: molecular epidemiology and risk factors for transmission in Piaui, Northeastern Brazil.
de Oliveira EH; Oliveira-Filho AB; Souza LA; da Silva LV; Ishak MO; Ishak R; Vallinoto AC
Curr HIV Res; 2012 Dec; 10(8):700-7. PubMed ID: 23016526
[TBL] [Abstract][Full Text] [Related]
10. Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1.
Silva MT; Neves ES; Grinsztejn B; de Melo Espíndola O; Schor D; Araújo A
AIDS; 2012 Feb; 26(4):521-3. PubMed ID: 21881482
[TBL] [Abstract][Full Text] [Related]
11. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV
Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902
[TBL] [Abstract][Full Text] [Related]
12. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain.
Vallejo A; Loza E; Mateos ML
J Clin Virol; 2015 Mar; 64():72-3. PubMed ID: 25728082
[No Abstract] [Full Text] [Related]
13. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
[TBL] [Abstract][Full Text] [Related]
14. In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
Machuca A; Soriano V
J Acquir Immune Defic Syndr; 2000 Jun; 24(2):189-93. PubMed ID: 10935697
[TBL] [Abstract][Full Text] [Related]
15. Human T-lymphotropic Virus Co-infections in Adults Infected With Human Immunodeficiency Virus.
Rossheim AE; Cunningham TD; Troy SB
Am J Med Sci; 2016 Sep; 352(3):258-60. PubMed ID: 27650229
[TBL] [Abstract][Full Text] [Related]
16. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals.
Pomier C; Rabaaoui S; Pouliquen JF; Couppié P; El Guedj M; Nacher M; Lacoste V; Wattel E; Kazanji M; Mortreux F
J Gen Virol; 2013 Apr; 94(Pt 4):753-757. PubMed ID: 23239567
[TBL] [Abstract][Full Text] [Related]
18. Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir.
Abad-Fernández M; Cabrera C; García E; Vallejo A
J Clin Virol; 2014 Mar; 59(3):204-7. PubMed ID: 24457115
[TBL] [Abstract][Full Text] [Related]
19. Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.
Toro C; Blanco F; García-Gascó P; Sheldon J; Benito JM; Rallón NI; Soriano V
Clin Infect Dis; 2007 Nov; 45(9):e118-20. PubMed ID: 17918071
[TBL] [Abstract][Full Text] [Related]
20. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
